PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China.\', \'Chengdu Rongsheng Pharmaceuticals Co., Ltd, Chengdu, China.\', \'Beijing Tiantan Biological Products Co., Ltd, Beijing, China.\', \'Wuhan Institute of Biological Products Co. Ltd, Wuhan, China.\', \'China National Biotec Group Company Limited, Beijing, China.\', \'Research Laboratory of Clinical Virology, Ruijin Hospital and Ruijin Hospital North, National Research Center for Translational Medicine, Shanghai Jiao Tong University of Medicine, Shanghai, China. zhangx@shsmu.edu.cn.\', \'China National Biotec Group Company Limited, Beijing, China. yangxiaoming@sinopharm.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41467-021-24230-5
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 34230476
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
?:title
  • Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all